trial

Improving Real-world Function for Persons with Schizophrenia: a Single-case Experimental Design

NCTId NCT06790186
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 27 (estimated)
Sponsored by Sykehuset Innlandet HF
Primary completion 2028-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
27 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2025-02-01
Primary completion
2028-12-31
Eligibility
ALL · 18 Years · 59 Years

Interventions & indications

Drugs
Perceive, Recall, Plan and Perform intervention Interventions:

Sponsors

Sykehuset Innlandet HFLead Sponsor
Norwegian University of Science and TechnologyCollaborator

Investigators

1
Elisabeth Haug, PhDStudy Chair

Sites

0 total

Facts & assertions

4 sourced
Enrollment
27
Phase
NA
Primary Completion Date
2028-12-31
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
Perceive, Recall, Plan and Perform intervention Interventions:
drug
lead_sponsor
Sykehuset Innlandet HF
company
collaborator
Norwegian University of Science and Technology
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Elisabeth Haug, PhD
person